Department of Veterans Affairs

Functional Endoscopic Sinus Surgery (FESS)

Clinical Determination and Indication Number: 00057
Original Effective Date: July 1, 2025
Last Review Date: July 1, 2025

I. Disclaimer

This document is intended to be used as a reference for non-VA providers and is not intended to replace clinical judgment when determining care pathways. These guidelines do not guarantee benefits or constitute medical advice.

II. Clinical Determinations and Indications

  1. Indications for Functional Endoscopic Sinus Surgery
    Functional endoscopic sinus surgery (FESS) is indicated for the treatment of obstructive sinus conditions and will be considered medically necessary when ANY of the following criteria are met:
    • Chronic rhinosinusitis (CRS) with or without polyps with ALL the following:
      • Episode has lasted longer than 12 weeks
      • Persistent symptoms such as pain, sinus pressure, or drainage that have failed a full course of the following medical treatments:
        • Corticosteroids, may be oral, nasal, or both, for six weeks
        • Antibiotic therapy of at least seven days, if bacterial infection is suspected
        • Nasal lavage/irrigation for at least six weeks, if appropriate
      • Nasal endoscopy evidence of CRS
      • Computed tomography (CT) scan confirmation of chronic rhinosinusitis (images are obtained after completion of medical management as identified above)
      • Computed tomography scan shows at least one of the following:
        • Bony remodeling
        • Bony thickening
        • Opacified sinus
        • Ostial obstruction and mucosal thickening
    • Recurrent acute rhinosinusitis (RARS) with ALL the following:
      • Four or more episodes within 12 consecutive months, with complete resolution of symptoms between each occurrence
      • Episodes with symptoms such as pain, sinus pressure, or drainage have recurred despite a full course of medical management with ALL the following treatments:
        • Corticosteroids, may be oral, nasal, or both, for six weeks
        • Antibiotic therapy of at least seven days, if bacterial infection is suspected
        • Nasal lavage/irrigation for at least six weeks, if appropriate
    • Any of the following conditions confirmed on CT scan:
      • Complications of sinusitis such as abscess
      • Fungal sinusitis
      • Symptomatic concha bullosa
      • Symptomatic mucocele
      • Polyposis with obstructive symptoms
      • Sinonasal tumor
      • Trauma related issues including fractures or cerebral spinal fluid (CSF) leaks involving the sinuses
      • Encephalocele
  1. Limitations/Exclusions
    Functional Endoscopic Sinus Surgery is not indicated and therefore considered not medically necessary in the following situations:
    • As a primary treatment for an obstructive sleep disorder
    • Allergic rhinitis
  1. Description of Treatment
    Functional endoscopic sinus surgery is a minimally invasive surgical procedure used to restore normal drainage of the sinuses. A preoperative CT scan of the sinuses is essential to define the anatomy and guide the surgery.

    The procedure is performed using a nasal endoscope that is inserted through the nostrils and allows direct visualization of the sinus cavities without the need for external incisions. Once the sinus cavities are visualized, the surgeon removes any blockages such as polyps, swollen tissue, or bone fragments that are obstructing sinus drainage. In some cases, a balloon is also inflated in the sinus openings to expand the drainage pathways.

    Note: Balloons used for sinus procedures are intended for single patient use only, per U.S. Food & Drug Administration (FDA) guidelines.

III. Background and Supporting Information

The following information is for reference purposes only in accordance with the medical benefits package outlined in 38 C.F.R. § 17.38 (b). Each subsection supports VA’s determinations for medical necessity and alignment with generally accepted standards of medical practice.

  1. Background Information
    Rhinosinusitis is the inflammation of the para-nasal sinuses and nasal cavity that may or may not be the result of an infection. Acute rhinosinusitis (ARS) is comprised of episodes that last up to 12 weeks and completely resolve but frequently return. Chronic rhinosinusitis (CRS) is defined as episodes that last greater than 12 weeks and frequently results in worsening symptoms over time. The most common symptoms are nasal congestion, nasal drainage, and facial pain or pressure. These symptoms generally result in compromised quality of life.

    Functional Endoscopic Sinus Surgery
    Functional endoscopic sinus surgery (FESS) is the gold standard for treating rhinosinusitis and other conditions that result in impaired sinus drainage. It is performed when other treatments such as antibiotics, steroids, nasal sprays, and antihistamines have failed to provide relief from symptoms. The goal of FESS is to increase airflow through the nose by opening blocked sinus passages and improve drainage of mucous and other fluids from the sinuses.

    While rhinosinusitis is the most common condition treated, FESS may also be used to treat other conditions, such as complications of sinusitis: abscess, concha bullosa, mucocele, Graves’ ophthalmopathy, nasolacrimal duct obstruction and dacryocystitis, and polyposis with obstructive symptoms or sinonasal tumor. Functional endoscopic sinus surgery is considered a less invasive and less traumatic procedure, compared to other sinus surgeries, resulting in shorter surgery and healing times, less postoperative discomfort, and fewer surgical complications.

  1. Research, Clinical Trials, and Evidence Summaries
    The use of FESS for the treatment of chronic, recurrent, and/or other sinus conditions has been supported by research, scientific evidence, and embraced by several professional societies. Numerous studies have demonstrated the efficacy and safety of FESS as it significantly improves sinus function, reduces symptoms of chronic sinusitis, and enhances the quality of life for patients.

    The International consensus statement on allergy and rhinology: rhinosinusitis 2021 presents clinical guidelines that are based on research and scientific evidence for what causes rhinosinusitis and how it should be treated. Evidence indicates that prolonging the time between diagnosis and surgery for chronic rhinosinusitis (CRS) may negatively impact outcomes. The statement cited Hopkins et al. which analyzed United Kingdom (UK) data via a prospective audit of surgery from CRS and UK primary care electronic datasets. Patients were classified according to the duration of their CRS until their first surgical intervention for CRS. Patients in the early group (e.g., less than 12 months) had a greater percentage improvement in their symptoms and the improvement was maintained over five years.

    The European position paper on rhinosinusitis and nasal polyps from 2020 provides evidence-based recommendations that synthesize research to guide clinical practice. These guidelines were developed through a systematic review of literature and expert consensus. Consensus papers and randomized controlled trials (RCTs) compared traditional and advanced techniques, including powered instrumentation and image guided surgery, demonstrating their efficacy in improving disease control, symptom relief, and quality of life. Meta-analyses and RCTs confirm FESS’s effectiveness in reducing symptoms and the need for revision surgeries.

  1. U.S. Food & Drug Administration Information
    VA generally only approves use of medical devices that have received at least Food & Drug Administration (FDA) clearance for 510(k) Premarket Notification. The FDA has determined these Class II devices are substantially equivalent (SE) to legally marketed predicate devices and may be marketed in the U.S.

    To search for devices that have received FDA 510(k) clearance or Premarket Approval (PMA), please visit the FDA Devices database.

  1. Medicare Coverage Determinations
    There are no available Medicare national and local coverage determinations for FESS. VA and Medicare are governed by separate laws and regulations; thus, VA coverage determinations may be different.
  1. Health Care Procedural Coding Information
    The following CPT®/HCPCS codes listed in this section are provided for informational purposes only. Inclusion or exclusion of a code does not constitute or imply VA coverage or provider reimbursement. The list of codes may not be all-inclusive since the American Medical Association (AMA) and Centers for Medicare & Medicaid Services (CMS) code updates may occur more frequently than CDI updates. Please refer to section II.a. in this document to review indications and clinical criteria for medical necessity.

    The following CPT codes are considered medically necessary/covered if the indications and clinical criteria outlined in section II.a. are met. Additional codes may also apply.

    CPT CodeDescription
    31237Nasal/sinus endoscopy, surgical; with biopsy, polypectomy, or debridement (separate procedure)
    31239Nasal/sinus endoscopy, surgical; with dacryocystorhinostomy
    31295Nasal/sinus endoscopy, surgical; with dilation of maxillary sinus ostium (e.g., balloon dilation), trans nasal or via canine fossa (Do not report 31295 in conjunction with 31233, 31256, 31267 when performed on the same sinus)
    31296Dilation of frontal sinus ostium (e.g., balloon dilation) (Do not report 31296 in conjunction with 31276 when performed on the same sinus)
    31297Dilation of sphenoid sinus ostium (e.g., balloon dilation) (Do not report 31297 in conjunction with 31235, 31287, 31288 when performed on the same sinus)
    31240Nasal/sinus endoscopy, surgical; with concha bullosa resection
    31253Nasal/sinus endoscopy, surgical with ethmoidectomy; total (anterior and posterior), including frontal sinus exploration, with removal of tissue from frontal sinus, when performed
    31254Nasal/sinus endoscopy, surgical with ethmoidectomy; partial (anterior)
    31255Nasal/sinus endoscopy, surgical with ethmoidectomy; total (anterior and posterior)
    31256Nasal/sinus endoscopy, surgical, with maxillary antrostomy
    31257Nasal/sinus endoscopy, surgical with ethmoidectomy; total (anterior and posterior), including sphenoidotomy
    31259Nasal/sinus endoscopy, surgical with ethmoidectomy; total (anterior and posterior), including sphenoidotomy, with removal of tissue from the sphenoid sinus
    31267Nasal/sinus endoscopy, surgical, with maxillary antrostomy; with removal of tissue from maxillary sinus
    31276Nasal/sinus endoscopy, surgical, with frontal sinus exploration, including removal of tissue from frontal sinus, when performed
    31287Nasal/sinus endoscopy, surgical, with sphenoidotomy
    31288Nasal/sinus endoscopy, surgical, with sphenoidotomy; with removal of tissue from the sphenoid sinus

    CPT copyright 2025 American Medical Association. All rights reserved.

IV. Definitions

TermDefinition
Acute Rhinosinusitis (ARS)A condition characterized by inflammation of the mucosa in the nose and paranasal sinuses, with sudden onset of symptoms of purulent nasal drainage accompanied by nasal obstruction, facial pain, pressure, or fullness of up to four weeks duration
Bony RemodelingChanges in bone thickness and density
Chronic Rhinosinusitis (CRS)Inflammation of the nasal mucosa and paranasal sinuses with associated signs and symptoms persisting over a 12-week consecutive duration
ConchaCurved, shelf-like bones that protrude from the sides of the nasal cavity that increase the surface area of the nasal cavities, and warm and humidify inhaled air
Concha BullosaAn air-filled cavity within a nasal concha, also known as a turbinate
CorticosteroidsA fast-acting class of drugs that can reduce inflammation
Ethmoid SinusA pair of hollow spaces in the ethmoid bone, located between the eyes and behind the bridge of the nose
Frontal SinusA pair of large, hollow spaces in the frontal bone of the skull located in the frontal bone, forming the lower portion of the forehead, and extending over the eyebrows and eye sockets
LavageWashing out a body cavity, such as the sinus, with water or a medicated solution
Maxillary Sinus A pair of large, pyramid-shaped cavities in the cheekbones, next to the nose
MucoceleA benign, mucus-filled cyst that grows in the sinuses
Mucosal ThickeningAn inflammatory reaction in the sinuses that causes the mucous lining to thicken
Opacified SinusA sinus that has become cloudy or opaque
Ostial ObstructionPersistent obstruction of the sinus ostium by inflammatory edema causing secondary bacterial colonization
PolypsAn abnormal growth of tissue that can appear in various parts of the body, such as the nose
Recurrent Acute rhinosinusitis (RARS)Four or more recurrent episodes of acute rhinosinusitis with complete clearing of symptoms between episodes over a one-year period
SinonasalReferring to the nose and sinuses
Sphenoid SinusA pair of hollow spaces in the skull’s sphenoid bone that are lined with mucus-producing cells located behind the nose, between the eyes

V. References

American Academy of Otolaryngology–Head and Neck Surgery (AAO-HNS). (2021). Clinical Indicators: Endoscopic Sinus Surgery, Adult.

Fokkens, W. J., Lund, V. J., Hopkins, C., Kern, R., Reitsma, S., Bernal-Sprekelsen, M., & Mullol, J. (2020, February 20). European position paper on Rhinosinusitis and nasal polyps 2020.

Hopkins, C., Rimmer, J., & Lund, V. J. (2015). Does time to endoscopic sinus surgery impact outcomes in Chronic Rhinosinusitis? Prospective findings from the National Comparative Audit of Surgery for Nasal Polyposis and Chronic Rhinosinusitis. Rhinology, 53(1), 10–17.

Orlandi, R. R., Kingdom, T. T., Smith, T. L., Bleier, B., DeConde, A., Luong, A. U., Poetker, D. M., Soler, Z., Welch, K. C., Wise, S. K., Adappa, N., Alt, J. A., Anselmo-Lima, W. T., Bachert, C., Baroody, F. M., Batra, P. S., Bernal-Sprekelsen, M., Beswick, D., Bhattacharyya, N., Chandra, R. K., … Zhou, B. (2021). International consensus statement on allergy and rhinology: rhinosinusitis 2021. International forum of allergy & rhinology, 11(3), 213–739.U.S. Food & Drug Administration 510(k) Premarket Notification Database. (n.d.). Retrieved October 8, 2024.

VI. CDI History/Revision Information

DateSummary of Updates
07/17/2025New CDI created describing medically necessary indications

We’re here anytime, day or night – 24/7

If you are a Veteran in crisis or concerned about one, connect with our caring, qualified responders for confidential help. Many of them are Veterans themselves.